Use of miltefosine in a patient with mucosal leishmaniasis and HIV-coinfection: A challenge in long-term management

Giacomo Zanelli, Barbara Rossetti, Roberta Gagliardini, Lorenzo Paglicci, Giacinta Tordini, Clelia Miracco, Sara Aversa, Lorenzo Zammarchi, Trentina Di Muccio, Marina Gramiccia, Francesca Montagnani

Research output: Contribution to journalArticlepeer-review

Abstract

The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limited data are available on the use of miltefosine for treatment and secondary prophylaxis. We describe a case of mucosal leishmaniasis in an HIV-coinfected patient treated with miltefosine due to a severe allergic reaction to liposomal amphotericin B.

Original languageEnglish
Pages (from-to)452-455
Number of pages4
JournalInfezioni in Medicina
Volume27
Issue number4
Publication statusPublished - Dec 1 2019

Keywords

  • Adverse reaction
  • HIV
  • Liposomal B amphotericin
  • Miltefosine
  • Mucosal leishmaniasis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Use of miltefosine in a patient with mucosal leishmaniasis and HIV-coinfection: A challenge in long-term management'. Together they form a unique fingerprint.

Cite this